Neurodegenerative Diseases (eBook, ePUB)
Translational Models, Mechanisms, and Therapeutics
Redaktion: Rai, Sachchida Nand; Singh, Santosh Kumar; Singh, Sandeep
52,95 €
52,95 €
inkl. MwSt.
Sofort per Download lieferbar
26 °P sammeln
52,95 €
Als Download kaufen
52,95 €
inkl. MwSt.
Sofort per Download lieferbar
26 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
52,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
26 °P sammeln
Neurodegenerative Diseases (eBook, ePUB)
Translational Models, Mechanisms, and Therapeutics
Redaktion: Rai, Sachchida Nand; Singh, Santosh Kumar; Singh, Sandeep
- Format: ePub
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This reference book provides a comprehensive overview of models and therapeutic approaches against neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, Huntington's disease, and Amyotrophic lateral sclerosis.
- Geräte: eReader
- mit Kopierschutz
- eBook Hilfe
- Größe: 4.42MB
Andere Kunden interessierten sich auch für
- Neurodegenerative Diseases (eBook, PDF)52,95 €
- Neurology and Pregnancy (eBook, ePUB)187,95 €
- Neurogenetics, Part I (eBook, ePUB)187,95 €
- Pierfausto SeneciChemical Modulators of Protein Misfolding and Neurodegenerative Disease (eBook, ePUB)53,95 €
- Parkinsonism Beyond Parkinson's Disease (eBook, ePUB)129,95 €
- The Molecular and Cellular Basis of Neurodegenerative Diseases (eBook, ePUB)67,95 €
- Magisetty ObulesuPlant Extracts in Neurodegenerative Diseases (eBook, ePUB)96,95 €
-
-
-
This reference book provides a comprehensive overview of models and therapeutic approaches against neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, Huntington's disease, and Amyotrophic lateral sclerosis.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Erscheinungstermin: 2. Dezember 2024
- Englisch
- ISBN-13: 9781040160176
- Artikelnr.: 72285386
- Verlag: Taylor & Francis
- Erscheinungstermin: 2. Dezember 2024
- Englisch
- ISBN-13: 9781040160176
- Artikelnr.: 72285386
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Dr. Sachchida Nand Rai is a Research Associate (ICMR-RA) at Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University (BHU), Varanasi since 27th Jan 2023. Dr. Rai also completed his Ph.D from the Biochemistry Department (Institute of Science) from BHU. Before joining the BHU as Research Associate, he was post-Doctoral fellow at Centre of Biotechnology, University of Allahabad, Prayagraj, India. He has published several research articles in high impact journals and has published 3 books. Dr. Rai serves as editorial board member in many reputed journals. He is investigating the neuroprotective activity of common Indian medicinal plants in toxin induced Parkinsonian mouse model. He is also member of the Indian Academy of Neurosciences, (India). Dr. Sandeep Singh is a Post-Doctoral Fellow at Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, California, USA. Before joining the Salk Institute, he was post-Doctoral fellow at Hadassah Biological Psychiatry Laboratory, Hadassah - Hebrew University Medical Center, Jerusalem, Israel. During PhD, he has presented his work in many world-renowned international neuroscience conferences such as Society for Neuroscience (USA), International Society for Neurochemistry (Paris), Japan Neuroscience Society (Japan). He was a recipient of IBRO-APRC Exchange Fellowship (2019) to work at National Institute of Advanced Industrial Science & Technology (AIST), Japan and Senior Research fellowship (2018) from Indian Council of Medical Research, India. He has published several research articles in journals of high repute. He is investigating the potential role of natural compounds and how they modulate the different molecular pathways during aging and age associated diseases. He is also member of the Indian Science Congress Association (India), Indian Academy of Neurosciences, (India). Dr. Santosh Kumar Singh is a Senior Scientist at Centre of Experimental Medicine and Surgery (CEMS), Faculty of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi-221005, India. He has completed his Ph.D. from the Botany Department (Institute of Science), BHU in 1998. He was a Visiting Scientist at Department of Photosynthesis, Institute of Physical Biology, University of South Bohemia, Czech Republic, in 2003. He has published more than 75 research articles in high impact factor journal and has published several books. Drug Discovery & Development, Microbial Biotechnology and Nanobiotechnology are some of his major areas of research. He is also Life time member of Mycological society of India, Life time member of Society of Biological Chemists, India, Member of the Society for Ethnopharmacology, Kolkata, India (SFE-INDIA). He was also participated as resource person in Karyashala Training Course Under Accelerate Vigyan Scheme, SERB, DST. He was awarded with "National Award for "Outstanding Efforts in Science and Technology Communication through Innovative and Traditional methods (2021)" conferred by Department of Science and Technology, Ministry of Science and Technology, Government of India. He was also received the order of academic excellence in publication (2020-2021), Institute of Medical Sciences, Banaras Hindu University, Varanasi.
1: General Introduction to Different Neurodegenerative Diseases.
2: Chemical-Induced Parkinson's disease model and associated therapeutic
strategies.
3: Recent advancement in the treatment of Parkinson's disease cellular
models.
4: Relevance of genetic model and linked therapeutics in Parkinson's
disease.
5: Importance of Newer 3D Organoids model based therapeutic approach in
Parkinson's disease.
6: Chemical Induced Alzheimer's disease model and their therapeutic
significance along with limitations.
7: Advancement in the Genetic Model of Alzheimer's disease.
8: Organoids and Alzheimer's disease.
9: Importance of Genetic Model in Huntington's disease.
10: Natural source of drugs for neurodegenerative diseases.
11: Limitations of modelling in different neurodegenerative diseases.
12: Significance of 3D Organoid Model in Neurodegenerative Diseases.
13: Recent advancement in therapeutics of rare neurological disorders.
14: Bio-informatics based modeling in different neurodegenerative diseases
and associated therapeutic strategies.
15: Holistic Management of Diverse Neurodegenerative Diseases in Different
Translational Models.
16: Gene Therapy, OMICS Approaches, and Translational Neurodegenerative
Models: Recent Advancements and Future Perspectives.
17: Implication and importance of Stem cell therapy in a translational
model of neurodegenerative diseases.
2: Chemical-Induced Parkinson's disease model and associated therapeutic
strategies.
3: Recent advancement in the treatment of Parkinson's disease cellular
models.
4: Relevance of genetic model and linked therapeutics in Parkinson's
disease.
5: Importance of Newer 3D Organoids model based therapeutic approach in
Parkinson's disease.
6: Chemical Induced Alzheimer's disease model and their therapeutic
significance along with limitations.
7: Advancement in the Genetic Model of Alzheimer's disease.
8: Organoids and Alzheimer's disease.
9: Importance of Genetic Model in Huntington's disease.
10: Natural source of drugs for neurodegenerative diseases.
11: Limitations of modelling in different neurodegenerative diseases.
12: Significance of 3D Organoid Model in Neurodegenerative Diseases.
13: Recent advancement in therapeutics of rare neurological disorders.
14: Bio-informatics based modeling in different neurodegenerative diseases
and associated therapeutic strategies.
15: Holistic Management of Diverse Neurodegenerative Diseases in Different
Translational Models.
16: Gene Therapy, OMICS Approaches, and Translational Neurodegenerative
Models: Recent Advancements and Future Perspectives.
17: Implication and importance of Stem cell therapy in a translational
model of neurodegenerative diseases.
1: General Introduction to Different Neurodegenerative Diseases.
2: Chemical-Induced Parkinson's disease model and associated therapeutic
strategies.
3: Recent advancement in the treatment of Parkinson's disease cellular
models.
4: Relevance of genetic model and linked therapeutics in Parkinson's
disease.
5: Importance of Newer 3D Organoids model based therapeutic approach in
Parkinson's disease.
6: Chemical Induced Alzheimer's disease model and their therapeutic
significance along with limitations.
7: Advancement in the Genetic Model of Alzheimer's disease.
8: Organoids and Alzheimer's disease.
9: Importance of Genetic Model in Huntington's disease.
10: Natural source of drugs for neurodegenerative diseases.
11: Limitations of modelling in different neurodegenerative diseases.
12: Significance of 3D Organoid Model in Neurodegenerative Diseases.
13: Recent advancement in therapeutics of rare neurological disorders.
14: Bio-informatics based modeling in different neurodegenerative diseases
and associated therapeutic strategies.
15: Holistic Management of Diverse Neurodegenerative Diseases in Different
Translational Models.
16: Gene Therapy, OMICS Approaches, and Translational Neurodegenerative
Models: Recent Advancements and Future Perspectives.
17: Implication and importance of Stem cell therapy in a translational
model of neurodegenerative diseases.
2: Chemical-Induced Parkinson's disease model and associated therapeutic
strategies.
3: Recent advancement in the treatment of Parkinson's disease cellular
models.
4: Relevance of genetic model and linked therapeutics in Parkinson's
disease.
5: Importance of Newer 3D Organoids model based therapeutic approach in
Parkinson's disease.
6: Chemical Induced Alzheimer's disease model and their therapeutic
significance along with limitations.
7: Advancement in the Genetic Model of Alzheimer's disease.
8: Organoids and Alzheimer's disease.
9: Importance of Genetic Model in Huntington's disease.
10: Natural source of drugs for neurodegenerative diseases.
11: Limitations of modelling in different neurodegenerative diseases.
12: Significance of 3D Organoid Model in Neurodegenerative Diseases.
13: Recent advancement in therapeutics of rare neurological disorders.
14: Bio-informatics based modeling in different neurodegenerative diseases
and associated therapeutic strategies.
15: Holistic Management of Diverse Neurodegenerative Diseases in Different
Translational Models.
16: Gene Therapy, OMICS Approaches, and Translational Neurodegenerative
Models: Recent Advancements and Future Perspectives.
17: Implication and importance of Stem cell therapy in a translational
model of neurodegenerative diseases.